The global head and neck cancer diagnostics market was valued at USD 6.19 billion in 2014 and is projected to reach USD 12.6 billion by 2020, growing at a CAGR of 12.67% during the forecast period. Overall, head and neck cancers account for more than 550,000 cases annually (roughly 3-5 % of all cancer incidences) all over the world.
Generally, males are affected significantly more than females with a ratio ranging from 2:1 to 4:1. The market for head and neck cancer diagnostics is expected to increase year-on-year, correlating with the rising cases of this disease in most regions.
Some of the major trends driving the market are the rising cases of target diseases, growing geriatric population all over the world, and better healthcare initiatives by governments and various private organizations. An increase in the disposable incomes in many regions across the globe is an opportunity that this market could capitalize on and expand further in other regions of the world.
The global head and neck cancer diagnostics market has been segmented on the basis of various parameters. By type, it has been segmented into laryngeal and hypopharyngeal cancer, nasal cavity and paranasal sinus cancer, nasopharyngeal cancer, oral and oropharyngeal cancer, and salivary gland cancer.
By diagnostic methods, the market has been further segmented into diagnostic imaging equipment, endoscopy screening equipment, bioscopy screening tests, blood tests, and dental diagnostic methods. Lastly, the market has also been segmented on the basis of geography into the Americas, Europe, Asia-Pacific, and Africa.
Africa and Asia-Pacific, along with parts of Europe and certain regions in South America, have the highest incidence of head and neck cancer cases. These regions are prone to higher intake of alcoholic and tobacco products, which could be instrumental in the rising cases of head and neck cancer cases in these regions. In Asia-Pacific and Africa, India, China, and South Africa are the biggest markets for the overall head and neck cancer diagnostics market.
This report explains the market growth and forecasts for the head and neck cancer diagnostics market, with a specific focus on the markets for diagnostic imaging, endoscopy, biopsy, blood tests, and dental diagnosis. The key drivers, restraints, and opportunities have been incorporated in the study, with a competitive analysis of the market captured simultaneously. The market size estimates have been forecasted for the year 2020 for both the global and regional markets.
Some of the key players in the market are:
Manager – Partner Relations & International Marketing
Ph: +1-214-377-1121 (US)/ +44-020-3286-9338 (UK)